MedTrace Logo

CeraShield™ Endotracheal Tube Feasibility Study

NCT03716713 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-08-20

No results posted yet for this study

Summary

Single-arm, feasibility study to evaluate the Ceragenin Coated Endotracheal Tube (the CeraShield ETT) in adults who require intubation and are expected to be mechanically ventilated for ≥ 24 hours.

Conditions

  • Intubation, Intratracheal

Interventions

DEVICE

CeraShield Endotracheal Tube

Subjects requiring mechanical ventilation with be intubated with the CeraShield ETT

Sponsors & Collaborators

  • N8 Medical, LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-30
Primary Completion
2019-10-30
Completion
2019-10-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03716713 on ClinicalTrials.gov